Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgetics
申请人:Aventis Pharmaceuticals Inc.
公开号:EP2311824A1
公开(公告)日:2011-04-20
Heteroarylpiperidines, pyrrolidines, and piperazines
of the formula
wherein
X is -O-, -S-, -NH-, or -N(R2)-
R2 is selected from the group consisting of lower alkyl, aryl lower alkyl, aryl, cycloalkyl, aroyl, alkanoyl, alkoxycarbonyl and phenylsulfonyl groups;
p is 1 or 2
Y is hydrogen, lower alkyl, hydroxy, chlorine, fluorine, bromine, iodine, lower alkoxy, trifluoromethyl, nitro, or amino;
Q1 is selected from the group consisting of:
and
where Z is
are useful as antipsychotic and analgesic agents. The compounds are especially useful for treating psychoses by administering to a mammal a psychoses-treating effective amount of one of the compounds. Depot derivatives of the compounds are useful for providing long acting effects of the compounds. The compounds are also useful as analgesics by administering a pain-relieving effective amount of one of the compounds to a mammal.
式中X为-O-,-S-,-NH-或-N(R2)-,R2选自下列组:低烷基,芳基低烷基,芳基,环烷基,芳香酰基,烷酰基,烷氧羰基和苯基磺酰基基团;p为1或2;Y为氢,低烷基,羟基,氯,氟,溴,碘,低烷氧基,三氟甲基,硝基或氨基;Q1选自下列组:其中Z为,本发明化合物作为抗精神病和镇痛剂具有应用价值。该化合物特别适用于通过向哺乳动物施用化合物的精神病治疗有效量来治疗精神病。该化合物的沉积物衍生物可用于提供化合物的长效作用。该化合物也可通过向哺乳动物施用缓解疼痛的有效量的化合物来用作镇痛剂。